It also gave an update on flu, Covid and Respiratory Syncytial Virus (RSV) levels. It said flu levels decreased to "medium" ...
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果